Literature DB >> 24366173

The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis.

Yuta Sugiyama1, Yuichiro Hagiya1, Motowo Nakajima2, Masahiro Ishizuka2, Tohru Tanaka2, Shun-Ichiro Ogura1.   

Abstract

Our previous study demonstrated that 5-aminolevulinic acid (ALA) administered to mice stimulates oxidative phosphorylation by upregulation of the mitochondrial respiratory chain complex IV enzyme cytochrome c oxidase (COX). The present study investigated whether ALA disrupts the Warburg effect, which represents a shift in ATP generation from oxidative phosphorylation to glycolysis, protecting tumor cells against oxidative stress-mediated apoptosis. The human lung carcinoma cell line A549 exposed to ALA exhibited enhanced oxidative phosphorylation, which was indicated by an increase in COX protein expression and oxygen consumption. Furthermore, ALA suppressed glycolysis-mediated acidosis. This normalization of the ATP metabolic pathways significantly increased the generation of superoxide anion radical (O2•-) and the functional expression of active caspase-3, leading to caspase-dependent apoptosis. These data demonstrate that ALA inhibits the Warburg effect and induces cancer cell death. Use of this endogenous compound might constitute a novel approach to cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366173     DOI: 10.3892/or.2013.2945

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.

Authors:  Junkoh Yamamoto; Shingo Kakeda; Tetsuya Yoneda; Shun-Ichiro Ogura; Shohei Shimajiri; Tohru Tanaka; Yukunori Korogi; Shigeru Nishizawa
Journal:  Oncol Lett       Date:  2016-12-27       Impact factor: 2.967

2.  The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation.

Authors:  Mai Miura; Kensuke Ito; Maiko Hayashi; Motowo Nakajima; Tohru Tanaka; Shun-ichiro Ogura
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

3.  5-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages.

Authors:  Yuta Sugiyama; Yukari Hiraiwa; Yuichiro Hagiya; Motowo Nakajima; Tohru Tanaka; Shun-Ichiro Ogura
Journal:  BMC Immunol       Date:  2018-12-19       Impact factor: 3.615

4.  Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.

Authors:  Kenta Onishi; Makito Miyake; Yoshihiro Tatsumi; Shunta Hori; Yasushi Nakai; Sayuri Onishi; Yusuke Iemura; Takuya Owari; Yoshitaka Itami; Kota Iida; Satoshi Anai; Nobumichi Tanaka; Keiji Shimada; Kiyohide Fujimoto
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

5.  Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.

Authors:  Pritpal Kaur; Shreya Nagar; Madhura Bhagwat; Mohammad Uddin; Yan Zhu; Ivana Vancurova; Ales Vancura
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

6.  5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action.

Authors:  Mantas Grigalavicius; Somayeh Ezzatpanah; Athanasios Papakyriakou; Tine Therese Henriksen Raabe; Konstantina Yannakopoulou; Theodossis A Theodossiou
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

Review 7.  The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer.

Authors:  Lulu Zhang; Yi Lu; Xiaoli Ma; Yuanxin Xing; Jinbo Sun; Yanfei Jia
Journal:  Front Mol Biosci       Date:  2022-07-25

Review 8.  The Multifaceted Role of Heme in Cancer.

Authors:  Veronica Fiorito; Deborah Chiabrando; Sara Petrillo; Francesca Bertino; Emanuela Tolosano
Journal:  Front Oncol       Date:  2020-01-15       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.